Los Alamos National Lab validates Shine’s Mo-99 production process

| | Health Imaging | Molecular Imaging

Los Alamos National Laboratory in Los Alamos, N.M., has reportedly demonstrated the production and separation of molybdenum-99 (Mo-99) from uranium sulfate solution using a separation flow sheet designed by Argonne National Laboratory.

The demonstration validates Shine’s technology in that it utilized both a low-enriched uranium solution and the process flows that will be used in the company’s commercial operations, according to a press release issued by Monona, Wis.-based Shine Medical Technologies.

The demonstration found that more than 97 percent of the Mo-99 produced was recovered in the separation process, Shine said. This process, combined with other elements of Shine’s technology, could avoid the use of highly enriched uranium in the production of Mo-99.

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.